Literature DB >> 22520471

TRPV1 antagonists: clinical setbacks and prospects for future development.

Michael E Kort1, Philip R Kym.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22520471     DOI： 10.1016/B978-0-12-396493-9.00002-9

Source DB:  PubMed          Journal:  Prog Med Chem        ISSN： 0079-6468


× No keyword cloud information.
  22 in total

Review 1.  TRPs and pain.

Authors:  Yi Dai
Journal:  Semin Immunopathol       Date:  2015-09-15       Impact factor: 9.623

Review 2.  Transient receptor potential ion channels in primary sensory neurons as targets for novel analgesics.

Authors:  J Sousa-Valente; A P Andreou; L Urban; I Nagy
Journal:  Br J Pharmacol       Date:  2014-05       Impact factor: 8.739

Review 3.  Breaking barriers to novel analgesic drug development.

Authors:  Ajay S Yekkirala; David P Roberson; Bruce P Bean; Clifford J Woolf
Journal:  Nat Rev Drug Discov       Date:  2017-06-09       Impact factor: 84.694

Review 4.  Targeting nociceptive transient receptor potential channels to treat chronic pain: current state of the field.

Authors:  Magdalene M Moran; Arpad Szallasi
Journal:  Br J Pharmacol       Date:  2017-11-06       Impact factor: 8.739

5.  Inhibition of FAAH, TRPV1, and COX2 by NSAID-serotonin conjugates.

Authors:  Tyler M Rose; Christopher A Reilly; Cassandra E Deering-Rice; Clinton Brewster; Chelsea Brewster
Journal:  Bioorg Med Chem Lett       Date:  2014-10-28       Impact factor: 2.823

6.  Successful TRPV1 antagonist treatment for cardiac hypertrophy and heart failure in mice.

Authors:  Jaime S Horton; Cadie L Buckley; Alexander J Stokes
Journal:  Channels (Austin)       Date:  2012-12-06       Impact factor: 2.581

Review 7.  Pain transduction: a pharmacologic perspective.

Authors:  Dan M McEntire; Daniel R Kirkpatrick; Nicholas P Dueck; Mitchell J Kerfeld; Tyler A Smith; Taylor J Nelson; Mark D Reisbig; Devendra K Agrawal
Journal:  Expert Rev Clin Pharmacol       Date:  2016-05-23       Impact factor: 5.045

Review 8.  New therapies for non-cardiac chest pain.

Authors:  Carla Maradey-Romero; Ronnie Fass
Journal:  Curr Gastroenterol Rep       Date:  2014

9.  Blockade of transient receptor potential cation channel subfamily V member 1 promotes regeneration after sciatic nerve injury.

Authors:  Fei Ren; Hong Zhang; Chao Qi; Mei-Ling Gao; Hong Wang; Xia-Qing Li
Journal:  Neural Regen Res       Date:  2015-08       Impact factor: 5.135

Review 10.  New and future drug development for gastroesophageal reflux disease.

Authors:  Carla Maradey-Romero; Ronnie Fass
Journal:  J Neurogastroenterol Motil       Date:  2013-12-30       Impact factor: 4.924
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.